VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 55 filers reported holding VERACYTE INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $709,000 | -53.5% | 91,661 | -54.3% | 0.47% | -9.8% |
| Q3 2016 | $1,525,000 | +51.3% | 200,400 | 0.0% | 0.52% | +29.0% |
| Q2 2016 | $1,008,000 | -6.8% | 200,400 | 0.0% | 0.40% | -10.2% |
| Q1 2016 | $1,082,000 | -25.0% | 200,400 | 0.0% | 0.45% | +10.6% |
| Q4 2015 | $1,443,000 | +53.5% | 200,400 | 0.0% | 0.41% | +125.6% |
| Q3 2015 | $940,000 | -76.2% | 200,400 | -43.5% | 0.18% | -51.6% |
| Q2 2015 | $3,951,000 | +50.6% | 354,700 | -1.6% | 0.37% | +50.0% |
| Q1 2015 | $2,624,000 | -25.9% | 360,500 | -1.7% | 0.25% | -27.1% |
| Q4 2014 | $3,542,000 | -0.9% | 366,700 | 0.0% | 0.34% | -7.9% |
| Q3 2014 | $3,575,000 | -45.1% | 366,700 | -3.6% | 0.37% | -34.0% |
| Q2 2014 | $6,514,000 | +0.4% | 380,500 | +0.5% | 0.56% | +5.5% |
| Q1 2014 | $6,485,000 | +18.0% | 378,600 | -0.1% | 0.53% | +17.8% |
| Q4 2013 | $5,494,000 | – | 378,900 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |